BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA
23 results:

  • 1. dnmt3a Cooperates with YAP/TAZ to Drive Gallbladder cancer Metastasis.
    Xu S; Yuan Z; Jiang C; Chen W; Li Q; Chen T
    Adv Sci (Weinh); 2024 Apr; 11(16):e2308531. PubMed ID: 38380551
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. DNMT1/dnmt3a-mediated promoter hypermethylation and transcription activation of ICAM5 augments thyroid carcinoma progression.
    Li Z; Ying Y; Zeng X; Liu J; Xie Y; Deng Z; Hu Z; Yang J
    Funct Integr Genomics; 2024 Jan; 24(1):12. PubMed ID: 38228798
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The frequency of mutations in advanced thyroid cancer in Japan: a single-center study.
    Toda S; Iwasaki H; Okubo Y; Hayashi H; Kadoya M; Takahashi H; Yokose T; Hiroshima Y; Masudo K
    Endocr J; 2024 Jan; 71(1):31-37. PubMed ID: 38044137
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
    Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
    [No Abstract]    [Full Text] [Related]  

  • 5. dnmt3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP.
    Ye D; Wang Y; Deng X; Zhou X; Liu D; Zhou B; Zheng W; Wang X; Fang L
    Cell Death Dis; 2023 Feb; 14(2):106. PubMed ID: 36774339
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway.
    Li S; Hu J; Li G; Mai H; Gao Y; Liang B; Wu H; Guo J; Duan Y
    Cell Biol Toxicol; 2023 Aug; 39(4):1359-1375. PubMed ID: 36241925
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CircPTPRM accelerates malignancy of papillary thyroid cancer via miR-885-5p/dnmt3a axis.
    Chen D; Jiang X; Luo H; Hua Q; Zhang F
    J Clin Lab Anal; 2022 Oct; 36(10):e24688. PubMed ID: 36098040
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy.
    Xu S; Jiang C; Lin R; Wang X; Hu X; Chen W; Chen X; Chen T
    J Exp Clin Cancer Res; 2021 Nov; 40(1):373. PubMed ID: 34823564
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A CRISPR-Cas9-Based Near-Infrared Upconversion-Activated DNA Methylation Editing System.
    Chi J; Zhao J; Wei S; Li Y; Zhi J; Wang H; Hou X; Hu L; Zheng X; Gao M
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):6043-6052. PubMed ID: 33525876
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. LINC00922 regulates epithelial-mesenchymal transition, invasive and migratory capacities in breast cancer through promoting NKD2 methylation.
    Wang Y; Dong T; Wang P; Li S; Wu G; Zhou J; Wang Z
    Cell Signal; 2021 Jan; 77():109808. PubMed ID: 33045317
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
    Peng Y; Fang X; Yao H; Zhang Y; Shi J
    Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
    [No Abstract]    [Full Text] [Related]  

  • 12. miR-145 promotes miR-133b expression through c-myc and dnmt3a-mediated methylation in ovarian cancer cells.
    Li J; Zhang S; Zou Y; Wu L; Pei M; Jiang Y
    J Cell Physiol; 2020 May; 235(5):4291-4301. PubMed ID: 31612498
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic significance of dnmt3a alterations in Middle Eastern papillary thyroid carcinoma.
    Siraj AK; Pratheeshkumar P; Parvathareddy SK; Bu R; Masoodi T; Iqbal K; Al-Rasheed M; Al-Dayel F; Al-Sobhi SS; Alzahrani AS; Al-Dawish M; Al-Kuraya KS
    Eur J Cancer; 2019 Aug; 117():133-144. PubMed ID: 31280122
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mutations of genes including dnmt3a detected by next-generation sequencing in thyroid cancer.
    Guo LC; Zhu WD; Ma XY; Ni H; Zhong EJ; Shao YW; Yu J; Gu DM; Ji SD; Xu HD; Ji C; Yang JM; Zhang Y
    Cancer Biol Ther; 2019; 20(3):240-246. PubMed ID: 30252567
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Intermediate-Risk Papillary thyroid cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy.
    Llamas-Olier AE; Cuéllar DI; Buitrago G
    Thyroid; 2018 Oct; 28(10):1311-1317. PubMed ID: 30105948
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A Nomogram Based on the Characteristics of Metastatic Lymph Nodes to Predict Papillary thyroid Carcinoma Recurrence.
    Jianyong L; Jinjing Z; Zhihui L; Tao W; Rixiang G; Jingqiang Z
    Thyroid; 2018 Mar; 28(3):301-310. PubMed ID: 29439612
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. YAP/TAZ-mediated activation of serine metabolism and methylation regulation is critical for LKB1-deficient breast cancer progression.
    Wu Q; Li J; Sun S; Chen X; Zhang H; Li B; Sun S
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28931725
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Minimally invasive video-assisted thyroidectomy: reflections after more than 2400 cases performed.
    Miccoli P; Biricotti M; Matteucci V; Ambrosini CE; Wu J; Materazzi G
    Surg Endosc; 2016 Jun; 30(6):2489-95. PubMed ID: 26335076
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. B-RafV600E inhibits sodium iodide symporter expression via regulation of DNA methyltransferase 1.
    Choi YW; Kim HJ; Kim YH; Park SH; Chwae YJ; Lee J; Soh EY; Kim JH; Park TJ
    Exp Mol Med; 2014 Nov; 46(11):e120. PubMed ID: 25378232
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Mediastinal masses: case series].
    Monteiro R; Alfaro TM; Correia L; Simão A; Robalo Cordeiro C; Carvalho A; Costa JM
    Acta Med Port; 2011; 24(6):899-904. PubMed ID: 22713183
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.